FDA approves new genetic disorder drug
The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of noncancerous tumors on ...
The American Journal of Managed Care2d
FDA Approves Mirdametinib for Neurofibromatosis Type 1 with Plexiform Neurofibromas
Adult and pediatric patients with neurofibromatosis type 1 who have symptomatic plexiform neurofibromas that are not amenable ...
FDA approved the first new kind of pain medication in 27 years. Here’s how it works
The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...
JD Supra1d
FDA Publishes Rule Updating ‘Healthy’ Nutrient Content Claim
On December 27, 2024, the US Food and Drug Administration (FDA) published its final rule to update the definition for “healthy” claims on food ...
Becker's Hospital Review13d
FDA approves 1st-of-its-kind non-opioid pain medication
The FDA has approved suzetrigine, a new, non-opioid medication for adults with moderate to severe acute pain.
MedPage Today3d
FDA OKs Mirdametinib for Neurofibromatosis Type 1
Opens in a new tab or window The FDA on Tuesday approved mirdametinib (Gomekli) for adults and kids ages 2 and up with neurofibromatosis type 1 (NF1). Approval of the MEK inhibitor is specifically ...
Cure Today8d
FDA-Approved Calquence Combo Is First and Only of Its Kind in MCL
Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor ...
KESQ News11d
FDA approves first new type of pain medication in 25 years
(CNN) — The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to ... acting director of the FDA’s Center for Drug Evaluation and Research, said in ...